Glutamine enters the cell via SLC1A5 and is converted to Glu
Statistical analysis was performed using GraphPad Prism 7.0a, or as reported by the relevant computational tools
Last reviewed July 2021
Their ability to address early-stage and progressive disease stages reinforces their importance in diabetes care
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64